downregulated in SZ postmortem brain samples from females (Eastwood and Harrison,
2005, Mill et al., 2008).
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author ManuscriptprocessThese data are consistent with the epigenetic theory of major psychosis (Costa et al., 2002)and suggest that DNA-methylation or histone tail covalent modifications associated withGABAergic and glutamatergic gene promoters are important casual events in thepathogenesis of SZ and BP disorder. Furthermore, support for the hypothesis that anepigenetic chromatin remodeling pathology contributes to the downregulation ofGABAergic or glutamatergic genes in psychotic patients is sustained by clinical studiesconducted in the early 1970s (for review see Wyatt et al., 1971).Methionine, the precursor of SAM (the universal methyl donor utilized by DNMTs tomethylate cytosine in CpG islands), administered in large doses (10–20 g/day) for 3–4weeks to SZ patients was reported to exacerbate psychotic symptomatology. In both mouseFC and neuronal cultures, the administration of large doses of methionine induces anincrease in SAM and the hypermethylation of selective CpG-rich GABAergic promoters,including GAD67 and reelin, and facilitates the downregulation of their expression (Chen etal., 2007, Noh et al., 2005, Mitchell et al., 2005, Tremolizzo et al., 2002, 2005). Importantly,the brain levels of GAD65 and that of other housekeeping genes were not affected(Tremolizzo et al., 2002).DNA promoter methylation patterns in neurons constitute a dynamicIt was thought that in neurons, DNA methylation patterns were established during
development and remained stable thereafter (Razin and Shemer, 1995). However, there is
increasing evidence supporting the concept that in adult neurons, methylation patterns of
specific cytosine/guanine (CpG) dinucleotide-rich promoters change rapidly. Thus,
throughout life, DNA methylation provides a platform on which the environment can sculpt
the genome and affect neuronal phenotype profiles without altering genotypes (Szyf, 2005).
We tested this hypothesis in a behavioral, neuroanatomical, and biochemical epigenetic
mouse model of SZ (Tremolizzo et al., 2002, 2005, Tueting, 2010), treating mice
protractedly with methionine to induce reelin and GAD67 promoter hypermethylation (Fig.
1, left side). We quantified the ratio of 5 methyl cytosine (5mC) to the unmethylated
cytosine (C) of the murine reelin CpG-enriched promoter region from 340 to + 160 bp
(Fig. 2) or the murine GAD67 CpG-enriched promoter region from 760 to – 311 (Satta et
al., 2008) by measuring the fraction of reelin or GAD67 promoter immunoprecipitated by
specific anti-5mC or anti-methylcytosine binding protein-2 (MeCP2) antibodies with
competitive RT-PCR and mutated internal standards (Dong et al., 2005). The results
reported in Fig. 2 show that in the FC of mice treated for 14 days with methionine, the ratio
of 5mC/C promoters measured with these two antibodies is virtually identical. These results
were duplicated using methylation-specific PCR primers (MSP) (Dong et al., 2007). We
found that the ratio of 5mC/C in the reelin promoter region 340 to + 160 bp was
approximately proportional to the number of methylated CpG dinucleotides measured with
sodium bisulfate mapping (Fig. 2), (Dong et al., 2007, 2008, Tremolizzo et al., 2005).
DNA methylation and demethylation神经疾病靶点_生物学_自然科学_专业资料。Pharmacological...Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuroph...
et al.Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011; 20: 4786-4796. Rogd...
et al.Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011; 20: 4786-4796. Rogd...
热门文档